These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2835158)
1. Expression of alpha-amylase in human lung cancers. Tomita N; Matsuura N; Horii A; Emi M; Nishide T; Ogawa M; Mori T; Doi O; Matsubara K Cancer Res; 1988 Jun; 48(11):3292-6. PubMed ID: 2835158 [TBL] [Abstract][Full Text] [Related]
2. Expression of alpha-amylase isozymes in human thyroid tissues. Doi S; Tomita N; Higasiyama M; Yokouchi H; Horii A; Yasuda T; Kobayashi T; Takai S; Ogawa M; Mori T Cancer Res; 1991 Jul; 51(13):3544-9. PubMed ID: 2054791 [TBL] [Abstract][Full Text] [Related]
3. alpha-Amylase in resectable lung cancer. Lenler-Petersen P; Grove A; Brock A; Jelnes R Eur Respir J; 1994 May; 7(5):941-5. PubMed ID: 8050552 [TBL] [Abstract][Full Text] [Related]
4. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene. Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218 [TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2 in human lung carcinoma. Wolff H; Saukkonen K; Anttila S; Karjalainen A; Vainio H; Ristimäki A Cancer Res; 1998 Nov; 58(22):4997-5001. PubMed ID: 9823297 [TBL] [Abstract][Full Text] [Related]
6. Fine needle aspiration cytology of atypical carcinoid of the lung. Frierson HF; Covell JL; Mills SE Acta Cytol; 1987; 31(4):471-5. PubMed ID: 3037832 [TBL] [Abstract][Full Text] [Related]
7. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells. Gilbert JA; Frederick LM; Ames MM Clin Cancer Res; 2000 Nov; 6(11):4365-72. PubMed ID: 11106255 [TBL] [Abstract][Full Text] [Related]
8. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance. Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800 [TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638 [TBL] [Abstract][Full Text] [Related]
10. Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Yokota J; Akiyama T; Fung YK; Benedict WF; Namba Y; Hanaoka M; Wada M; Terasaki T; Shimosato Y; Sugimura T Oncogene; 1988 Oct; 3(4):471-5. PubMed ID: 2856251 [TBL] [Abstract][Full Text] [Related]
11. Amylase in lung carcinomas. An ultrastructural and immunohistochemical study of two adenocarcinomas, and a review of the literature. Grove A APMIS; 1994 Feb; 102(2):135-44. PubMed ID: 7513172 [TBL] [Abstract][Full Text] [Related]
12. Preferential transcription of a gene for alpha amylase in the carcinoid tumor of African rodent Mastomys natalensis. Daa T; Sato T; Kashima K; Nakayama I; Yokoyama S; Takeno S; Noguchi T; Uchida Y J Exp Clin Cancer Res; 2002 Mar; 21(1):131-6. PubMed ID: 12071519 [TBL] [Abstract][Full Text] [Related]
13. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer. Gu C; Oyama T; Osaki T; Kohno K; Yasumoto K Anticancer Res; 2001; 21(4A):2357-62. PubMed ID: 11724293 [TBL] [Abstract][Full Text] [Related]
14. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients. Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123 [TBL] [Abstract][Full Text] [Related]
15. Higher expression of topoisomerase II in lung cancers than normal lung tissues: different expression pattern from topoisomerase I. Hasegawa T; Isobe K; Nakashima I; Shimokata K Biochem Biophys Res Commun; 1993 Aug; 195(1):409-14. PubMed ID: 8395833 [TBL] [Abstract][Full Text] [Related]
16. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320 [TBL] [Abstract][Full Text] [Related]
17. Lung carcinoma metastatic to the ovary: a clinicopathologic study of 32 cases emphasizing their morphologic spectrum and problems in differential diagnosis. Irving JA; Young RH Am J Surg Pathol; 2005 Aug; 29(8):997-1006. PubMed ID: 16006793 [TBL] [Abstract][Full Text] [Related]
18. Somatic alterations of the serine/threonine kinase LKB1 gene in squamous cell (SCC) and large cell (LCC) lung carcinoma. Strazisar M; Mlakar V; Rott T; Glavac D Cancer Invest; 2009 May; 27(4):407-16. PubMed ID: 19229701 [TBL] [Abstract][Full Text] [Related]
19. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis. van de Velde HJ; Senden NH; Roskams TA; Broers JL; Ramaekers FC; Roebroek AJ; Van de Ven WJ Cancer Res; 1994 Sep; 54(17):4769-76. PubMed ID: 8062278 [TBL] [Abstract][Full Text] [Related]
20. Incidence of latent infection of Epstein-Barr virus in lung cancers--an analysis of EBER1 expression in lung cancers by in situ hybridization. Kasai K; Sato Y; Kameya T; Inoue H; Yoshimura H; Kon S; Kikuchi K J Pathol; 1994 Dec; 174(4):257-65. PubMed ID: 7884587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]